According to Directive 2001/20 / EC Article 19, any non-European sponsor that lead clinical research studies in one or more countries of the European Union must have a legal representative to ensure compliance with regulations and requirements applied.
Being aware of the need for globalization of drug development, Sermes CRO has expanded its services offering legal representation and advice to non-European promoters sponsors through Sermes UK.
Sermes UK offers an agile and effective management; enabling European clinical trial to conduct presentations within a short period of time. To make this possible, we have a team of experts in regulation and legislation prepared to advise about the coverage of legal representation throughout the framework of the European Union a team of experts in regulation and legislation prepared at all times to advice about the legal representation coverage throughout the European Union framework.
Are you interested? Let’s talk now